Core Viewpoint - A class action lawsuit has been filed against China Liberal Education Holdings, Ltd. for alleged securities fraud involving a "pump-and-dump" scheme that resulted in estimated losses exceeding $300 million [2][3]. Group 1: Lawsuit Details - The lawsuit, titled Atul Shah, et al. v. China Liberal Education Holdings Ltd., et al., was filed in the Southern District of New York and involves claims against the company's officers, directors, and associated service providers [1]. - The class period for the lawsuit is defined as January 22, 2025, to January 30, 2025, during which investors can seek appointment as lead plaintiff [1][3]. - The allegations include violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1]. Group 2: Investor Participation - Investors who purchased or acquired common stock of CLEU during the class period are eligible to seek lead plaintiff status but are not required to do so to participate in any future recovery [3]. - The plaintiffs intend to apply for lead plaintiff status and seek the appointment of Morris Kandinov LLP as lead counsel [3]. Group 3: Financial Implications - The alleged "pump-and-dump" scheme is said to have caused losses estimated to exceed $300 million, indicating significant financial implications for investors involved [2].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of New Era Energy & Digital, Inc. due to allegations of materially misleading business information issued by the company [1] Group 1: Legal Action and Investor Rights - Investors who purchased New Era Energy & Digital securities may be entitled to compensation through a contingency fee arrangement, with a class action being prepared to recover investor losses [2] - To join the prospective class action, investors can submit a form or contact the law firm directly for more information [2] Group 2: Company Performance and Allegations - New Era Energy & Digital's stock fell 6.9% on December 12, 2025, following a report from Fuzzy Panda Research that criticized the company's financial practices, alleging excessive spending on stock promotions compared to operational costs [3] - The report claimed that the CEO has a history of mismanaging penny stock companies over the past 20 years [3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for the number of settlements [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has received recognition for its attorneys [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Blue Owl Capital Inc. securities between February 6, 2025, and November 16, 2025, of the upcoming lead plaintiff deadline on February 2, 2026, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Blue Owl securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the Court by February 2, 2026 [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4]. Group 3: Case Allegations - The lawsuit alleges that during the Class Period, Blue Owl made false or misleading statements and failed to disclose significant issues, including pressure on its asset base from business development companies (BDCs) redemptions and undisclosed liquidity issues [5]. - As a result of these undisclosed issues, Blue Owl was likely to limit or halt redemptions of certain BDCs, and the defendants downplayed the severity of the negative impacts, leading to materially misleading statements about the company's business and prospects [5].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Alvotech due to allegations of materially misleading business information issued by the company [1] Group 1: Legal Action and Investor Rights - Shareholders who purchased Alvotech securities may be entitled to compensation through a class action without any out-of-pocket fees, facilitated by a contingency fee arrangement [2] - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to Alvotech [2] Group 2: Company Performance and Stock Impact - On November 2, 2025, Alvotech announced that the FDA issued a complete response letter for its Biologics License Application for AVT05, citing deficiencies from a pre-license inspection of its Reykjavik manufacturing facility [3] - Following this announcement, Alvotech's stock price dropped by 34% on November 3, 2025, and nearly 4% on November 4, 2025 [3] Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for settlements since 2013 [4] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased F5, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - The Class Period for the F5 securities lawsuit is from October 28, 2024, to October 27, 2025 [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 17, 2026 [2] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [3] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013 [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [3] Group 3: Case Allegations - The lawsuit alleges that F5 misrepresented its revenue outlook and growth potential while downplaying risks associated with seasonality and macroeconomic factors [4] - It is claimed that F5's optimistic statements about its security capabilities were misleading, as the company was facing a significant security incident that jeopardized its future prospects [4] - The lawsuit asserts that when the true information became public, investors suffered damages due to the misleading claims made by F5 [4]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Trip.com Group Limited due to allegations of materially misleading business information [1] Group 1: Legal Action and Investor Rights - Investors who purchased Trip.com Group Limited securities may be entitled to compensation through a contingency fee arrangement without any out-of-pocket costs [2] - Rosen Law Firm is preparing a class action to seek recovery of investor losses [2] Group 2: Market Reaction and Regulatory Investigation - On January 14, 2026, Trip.com stock fell 17% after the company disclosed it is under investigation by China's market regulator for potential antitrust violations [3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [4] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [4] - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Alvotech due to allegations of materially misleading business information issued by the company [1]. Group 1: Company Information - Alvotech's stock price experienced a significant decline of 34% on November 3, 2025, following the announcement of a complete response letter (CRL) from the U.S. FDA regarding its Biologics License Application (BLA) for AVT05 [3]. - The CRL indicated that certain deficiencies identified during the FDA's pre-license inspection of Alvotech's Reykjavik manufacturing facility must be resolved before the BLA for AVT05 can be approved [3]. Group 2: Legal Actions - Investors who purchased Alvotech securities may be eligible for compensation through a class action lawsuit being prepared by Rosen Law Firm, which operates on a contingency fee basis [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering substantial amounts for investors [4].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential shareholder derivative claims against Starbucks Corporation regarding alleged breaches of fiduciary duties by certain officers and directors, following a securities class action related to the company's stock performance during a specified period [1][3]. Group 1: Investigation Details - The investigation is prompted by a securities class action complaint alleging that Starbucks and its senior executives made materially false and misleading statements and failed to disclose adverse facts [3]. - On April 30, 2024, Starbucks announced disappointing second-quarter fiscal 2024 results and lowered its full-year guidance, leading to a stock price drop from $88.49 to $74.44, a decline of over 15% in one day [3]. - The focus of the investigation includes whether the board of directors and senior management allowed misconduct, failed to implement adequate disclosure and risk-management controls, and exposed the company to financial and reputational harm [4]. Group 2: Shareholder Actions - Current Starbucks shareholders who held shares continuously before November 2, 2023, may have standing to pursue derivative claims on behalf of the company [2]. - Shareholders are encouraged to seek more information through the law firm's website or contact the lead analyst for further assistance [2].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Blue Owl Capital Inc. during the specified Class Period of the upcoming lead plaintiff deadline on February 2, 2026 [1]. Group 1: Class Action Details - Investors who bought Blue Owl securities between February 6, 2025, and November 16, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lawsuit claims that Blue Owl made false or misleading statements regarding its asset base and liquidity issues, which led to investor damages when the truth was revealed [5]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been recognized as a leader in the field of securities class action litigation [4].

SAN DIEGO, Jan. 27, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the allegations? Robbin ...